Terrance P. Coyne, EVP & CFO at Royalty Pharma plc (RPRX), sold 75,000 shares at $30.75 ($2.3M) on 2023-08-10, disclosed to the SEC on 2023-08-11.
Scheduled sale ($2.3M) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.72 | 37,500 | $1.2M | 50.0% |
| 2 | $30.75 | 37,500 | $1.2M | 50.0% |
| Total | $30.73 avg | 75,000 | $2.3M | 100% |
| Filing → |
| RPRX | SELL | 2026-04-30 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-04-02 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-03-25 | $3.2M | — | Filing → |